Hexakis(benzonitrile)ruthenium(II) bis[tetrafluoroborate(1-)]: a precursor to ruthenium organometallic compounds

[1]  S. Suib,et al.  Syntheses and X-ray crystal structures of two ruthenium(II) complexes derived from acetonitrile and dimethylphenylphosphonite , 2013 .

[2]  Julia L. Brumaghim,et al.  Synthesis and electrochemical characterization of [Ru(NCCH3)6]2+, tris(acetonitrile) tris(pyrazolyl)borate, and tris(acetonitrile) tris(pyrazolyl)methane ruthenium(II) complexes , 2013 .

[3]  Henrique S. Oliveira,et al.  Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships. , 2009, Bioorganic & medicinal chemistry.

[4]  P. M. Reddy,et al.  Substituted tertiary phosphine Ru(II) organometallics: catalytic utility on the hydrolysis of etofibrate in pharmaceuticals. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[5]  Beatriz Cordero,et al.  Covalent radii revisited. , 2008, Dalton transactions.

[6]  E. Singleton,et al.  (η4‐1, 5‐Cyclooctadiene)Ruthenium(II) Complexes , 2007 .

[7]  Shailendra Singh,et al.  Cyclooctadiene Ru(II) complexes of thiophene-2-carboxaldehyde-derived thiosemicarbazones: synthesis, characterization and antiamoebic activity. , 2006, European journal of medicinal chemistry.

[8]  H. Puschmann,et al.  Syntheses and molecular structures of group 8 benzonitrile complexes , 2005 .

[9]  N. Bharti,et al.  synthesis, characterization and in vitro antiamoebic activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones and their Palladium (II) and Ruthenium (II) complexes. , 2004, European journal of medicinal chemistry.

[10]  E. Meggers,et al.  Ruthenium complexes as protein kinase inhibitors. , 2004, Organic letters.

[11]  A. Anzellotti,et al.  Hexakis­(aceto­nitrile)­ruthenium(II) tetra­chloro­zincate 2.55-hydrate , 2001 .

[12]  N. Bharti,et al.  Synthesis, characterisation and antiamoebic activity of new thiophene-2-carboxaldehyde thiosemicarbazone derivatives and their cyclooctadiene Ru(II) complexes. , 2001, Bioorganic & medicinal chemistry letters.

[13]  R. Finke,et al.  POLYOXOANION- AND TETRABUTYLAMMONIUM-STABILIZED RH(0)N NANOCLUSTERS : UNPRECEDENTED NANOCLUSTER CATALYTIC LIFETIME IN SOLUTION , 1999 .

[14]  R. Finke,et al.  A review of modern transition-metal nanoclusters: their synthesis, characterization, and applications in catalysis , 1999 .

[15]  R. Finke,et al.  A perspective on nanocluster catalysis: polyoxoanion and (n-C4H9)4N+ stabilized Ir(0)∼300 nanocluster ‘soluble heterogeneous catalysts’ , 1996 .

[16]  K. Dunbar.  New Applications of Weak Donor Atoms to Coordination, Organometallic and Materials Chemistry , 1993 .

[17]  G. Lamprecht,et al.  The structure of acetylcarbonyltris(triphenylantimony) rhodium(I) , 1986 .

[18]  S. Wölfl,et al.  Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents. , 2012, Journal of inorganic biochemistry.

[19]  G. Heath,et al.  From [RuX6] to [Ru(RCN)6]: synthesis of mixed halide–nitrile complexes of ruthenium, and their spectroelectrochemical characterization in multiple oxidation states , 1991 .

[20]  J. Collman,et al.  Principles and applications of organotransition metal chemistry , 1980 .

[21]  R. Schrock,et al.  Reactivity of co-ordinated ligands. Part XVIII. Cationic ruthenium(II) and osmium(II) complexes by electrophilic attack on a π-allyl ligand , 1974 .